My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 101

    1.

    From a Parkinson's disease expert: Rasagiline and the future of therapy.

    Lakhan SE.

    Mol Neurodegener. 2007 Jul 6;2:13.PMID: 17617893 [PubMed]Related articlesFree article

    2.

    Rasagiline: a review of its use in the management of Parkinson's disease.

    Oldfield V, Keating GM, Perry CM.

    Drugs. 2007;67(12):1725-47. Review.PMID: 17683172 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment]

    Jost WH, Klasser M, Reichmann H.

    Fortschr Neurol Psychiatr. 2008 Oct;76(10):594-9. Epub 2008 Oct 2. German. PMID: 18833504 [PubMed - indexed for MEDLINE]Related articles

    5.

    Spotlight on rasagiline in Parkinson's disease.

    Oldfield V, Keating GM, Perry CM.

    CNS Drugs. 2008;22(1):83-6.PMID: 18072817 [PubMed]Related articles

    6.

    Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.

    Chen JJ, Swope DM, Dashtipour K.

    Clin Ther. 2007 Sep;29(9):1825-49. Review.PMID: 18035186 [PubMed - indexed for MEDLINE]Related articles

    7.

    Cost effectiveness of rasagiline and pramipexole as treatment strategies in early Parkinson's disease in the UK setting: an economic Markov model evaluation.

    Haycox A, Armand C, Murteira S, Cochran J, François C.

    Drugs Aging. 2009;26(9):791-801. doi: 10.2165/11316770-000000000-00000.PMID: 19728752 [PubMed - indexed for MEDLINE]Related articles

    8.

    Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease.

    Hauser RA, Lew MF, Hurtig HI, Ondo WG, Wojcieszek J, Fitzer-Attas CJ; TEMPO Open-label Study Group.

    Mov Disord. 2009 Mar 15;24(4):564-73.PMID: 19086083 [PubMed - indexed for MEDLINE]Related articles

    9.

    Faropenem medoxomil: A0026, BAY 56-6854, BAY 566854, faropenem daloxate, SUN 208, SUN A0026.

    [No authors listed]

    Drugs R D. 2008;9(2):115-24. Review.PMID: 18298129 [PubMed - indexed for MEDLINE]Related articles

    10.

    Rasagiline - a novel MAO B inhibitor in Parkinson's disease therapy.

    Lecht S, Haroutiunian S, Hoffman A, Lazarovici P.

    Ther Clin Risk Manag. 2007 Jun;3(3):467-74.PMID: 18488080 [PubMed - in process]Related articlesFree article

    11.

    Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease.

    Naoi M, Maruyama W.

    Expert Rev Neurother. 2009 Aug;9(8):1233-50.PMID: 19673610 [PubMed - indexed for MEDLINE]Related articles

    12.

    Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease.

    Gallagher DA, Schrag A.

    CNS Drugs. 2008;22(7):563-86. Review.PMID: 18547126 [PubMed - indexed for MEDLINE]Related articles

    13.

    Role of rasagiline in treating Parkinson's disease: Effect on disease progression.

    Malaty IA, Fernandez HH.

    Ther Clin Risk Manag. 2009 Aug;5(4):413-9. Epub 2009 Jun 4.PMID: 19753135 [PubMed - in process]Related articlesFree article

    14.

    [Figures of first laureates of the Wiktor Dega medal (XXXVII Jubilee Congress of Polish Orthopaedic and Traumatologic Society, 10-13 September 2008)]

    Nowakowski A, Rapała K.

    Chir Narzadow Ruchu Ortop Pol. 2008 Nov-Dec;73(6):397-401. Polish. PMID: 19241890 [PubMed - indexed for MEDLINE]Related articles

    15.

    Rasagiline in treatment of Parkinson's disease.

    Nayak L, Henchcliffe C.

    Neuropsychiatr Dis Treat. 2008 Feb;4(1):23-32.PMID: 18728823 [PubMed - in process]Related articlesFree article

    16.

    Chapter 33 The history of movement disorders.

    Lanska DJ.

    Handb Clin Neurol. 2009;95:501-46.PMID: 19892136 [PubMed - in process]Related articles

    17.

    Rasagiline: an anti-Parkinson drug with neuroprotective activity.

    Youdim MB.

    Expert Rev Neurother. 2003 Nov;3(6):737-49.PMID: 19810877 [PubMed - in process]Related articles

    18.

    Oblimersen: Augmerosen, BCL-2 antisense oligonucleotide - Genta, G 3139, GC 3139, oblimersen sodium.

    [No authors listed]

    Drugs R D. 2007;8(5):321-34. Review.PMID: 17767397 [PubMed - indexed for MEDLINE]Related articles

    19.

    The 2009 Lindau Nobel Laureate Meeting: Peter Agre, Chemistry 2003.

    Agre P.

    J Vis Exp. ;(34). pii: 1565.PMID: 20010539 [PubMed - indexed for MEDLINE]Related articles

    20.

    Occupational therapy for patients with Parkinson's disease.

    Dixon L, Duncan D, Johnson P, Kirkby L, O'Connell H, Taylor H, Deane KH.

    Cochrane Database Syst Rev. 2007 Jul 18;(3):CD002813. Review.PMID: 17636709 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk